REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 191 filers reported holding REPLIGEN CORP in Q2 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,736,576 | +12.8% | 23,499 | +0.3% | 0.51% | +22.7% |
| Q2 2023 | $3,313,559 | -15.9% | 23,424 | +0.0% | 0.41% | -19.3% |
| Q1 2023 | $3,941,981 | -55.9% | 23,414 | -55.6% | 0.51% | -57.8% |
| Q4 2022 | $8,935,674 | -32.9% | 52,777 | -25.9% | 1.22% | -33.7% |
| Q3 2022 | $13,318,000 | +11.3% | 71,178 | -3.4% | 1.83% | +20.3% |
| Q2 2022 | $11,961,000 | +60.1% | 73,649 | +85.4% | 1.52% | +80.1% |
| Q1 2022 | $7,473,000 | -25.4% | 39,733 | +5.1% | 0.85% | -15.9% |
| Q4 2021 | $10,017,000 | -5.7% | 37,822 | +2.9% | 1.01% | -10.4% |
| Q3 2021 | $10,623,000 | +55.6% | 36,758 | +7.5% | 1.12% | +37.6% |
| Q2 2021 | $6,829,000 | -0.9% | 34,209 | -3.5% | 0.82% | -0.7% |
| Q1 2021 | $6,894,000 | -1.5% | 35,459 | -3.0% | 0.82% | -8.5% |
| Q4 2020 | $7,002,000 | +7.2% | 36,537 | -17.5% | 0.90% | -7.3% |
| Q3 2020 | $6,531,000 | +8.5% | 44,267 | -9.1% | 0.97% | +9.4% |
| Q2 2020 | $6,018,000 | +28.0% | 48,687 | -0.1% | 0.89% | -5.7% |
| Q1 2020 | $4,703,000 | -39.3% | 48,717 | -41.8% | 0.94% | -22.4% |
| Q4 2019 | $7,745,000 | +19.9% | 83,727 | -0.6% | 1.21% | +11.8% |
| Q3 2019 | $6,459,000 | -11.1% | 84,227 | -0.4% | 1.08% | -11.2% |
| Q2 2019 | $7,266,000 | +45.9% | 84,537 | +0.3% | 1.22% | +37.4% |
| Q1 2019 | $4,981,000 | +10.3% | 84,307 | -1.6% | 0.89% | -2.7% |
| Q4 2018 | $4,516,000 | -28.2% | 85,637 | -24.5% | 0.91% | -9.4% |
| Q3 2018 | $6,290,000 | -12.4% | 113,417 | -25.7% | 1.01% | -21.9% |
| Q2 2018 | $7,182,000 | +19.0% | 152,677 | -8.5% | 1.29% | +17.5% |
| Q1 2018 | $6,035,000 | +113.1% | 166,817 | +113.7% | 1.10% | +106.4% |
| Q4 2017 | $2,832,000 | -6.1% | 78,051 | -0.8% | 0.53% | -10.4% |
| Q3 2017 | $3,015,000 | -8.0% | 78,676 | -0.5% | 0.59% | -12.0% |
| Q2 2017 | $3,276,000 | +9.8% | 79,066 | -6.7% | 0.68% | +7.8% |
| Q1 2017 | $2,984,000 | -12.5% | 84,786 | -23.3% | 0.63% | +7.4% |
| Q4 2016 | $3,409,000 | +1.7% | 110,606 | -0.4% | 0.58% | +6.2% |
| Q3 2016 | $3,351,000 | +10.1% | 111,011 | -0.2% | 0.55% | +6.2% |
| Q2 2016 | $3,043,000 | – | 111,221 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |